ACBI3 Targets KRASACBI3 Targets KRASMutationsKRAS-driven tumors.ACBI3 shows promise in reducingPharmacology and ToxicologyTargeting KRAS: ACBI3’s Potential in Cancer TreatmentACBI3 may effectively degrade KRAS mutations, improving cancer treatment options.2025-08-27T02:37:51+00:00 ― 5 min read